ctrl K

MoonLake Immunotherapeuti... (MLTX)

NASDAQ: MLTX · Real-Time Price · USD

42.09

1.91 (4.75%)

At close: Apr 30, 2025, 11:24 AM

MoonLake Immunotherapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	180.43M	451.17M	39.51M	8.04M	1.34M
Short-Term Investments	267.6B	59.84M	32.61M	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	115.04M	115.01M
Other Long-Term Assets	3.64B	8.42M	-0.00	-115.04M	n/a
Receivables	2.84M	1.06M	217.13K	148.77K	n/a
Inventory	n/a	n/a	n/a	1.32M	n/a
Other Current Assets	23.42B	n/a	n/a	n/a	n/a
Total Current Assets	474.29B	514.17M	76.51M	9.64M	1.62M
Property-Plant & Equipment	3.64M	3.95M	331.97K	45.74K	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	3.64B	12.37M	331.97K	45.74K	115.01M
Total Assets	477.93B	526.54M	76.84M	9.68M	116.63M
Account Payables	8.68M	n/a	47.48K	1.23M	n/a
Deferred Revenue	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	15M	58.06K
Other Current Liabilities	22.45B	259.73K	109.83K	1.3M	67.12K
Total Current Liabilities	22.46B	9.97M	7.67M	21.09M	125.18K
Long-Term Debt	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	2.08B	583.42K	282.21K	239.86K	4.03M
Total Long-Term Liabilities	2.08B	3.08M	411.16K	239.86K	4.03M
Total Liabilities	24.54B	13.05M	8.08M	21.33M	4.15M
Total Debt	2.83M	3.81M	282.58K	15M	58.06K
Common Stock	6.39K	6.3K	5.27K	38.54K	115M
Retained Earnings	-235.59B	-116.66M	-80.65M	-53.64M	-2.52M
Comprehensive Income	5M	2.36M	350.95K	-168.18K	n/a
Shareholders Equity	446.83B	495.68M	48.9M	-11.65M	112.48M
Total Investments	267.6B	59.84M	32.61M	115.04M	115.01M